Priority Date: 15.07.08 (US 20080080913P)

Heteroaryl derivatives as DGAT1 inhibitors

  • Application ID: EP12180191
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.07.2008 - Priority Date (US 20080080913P)
  • 23.01.2013 - Publication A2 (EP2548618)
  • 27.02.2013 - Publication A3 (EP2548618)